Question

Which pharma organisation has partnered with Merck KGaA and IAVI for development of SARS-CoV-2 neutralizing monoclonal antibodies?

• A. Bharat Biotech
• B. Serum Institute
• C. Cipla
• D. Ranbaxy

Answer 1

Answer:

B. Serum Institute

The Pune based Serum Institute of India has partnered with Merck KGaA and IAVI for development SARS-CoV-2 neutralising monoclonal antibodies. The Merck Group is a German multinational science and technology company. The International AIDS Vaccine Initiative (IAVI) is a global not-for-profit, public-private partnership working to accelerate the development of vaccines to prevent HIV infection and AIDS.